Posted on November 7th, 2009
Archived in Mad Money - Jim Cramer
Leave a comment
No Product Revenues, Plenty of Risk: Buy Exelixis?
Combining Bollinger Bands on Rates of Change in the VIX
This company’s anti-depressant drug should boost speculators’ spirits. Original Source >>>
Comments are closed.
Copyright © 2010 Stock Trading Alerts and Updates.
